These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 4404082)
21. [Changes induced by a new ergoline-like vasoactive substance on various parameters of the systemic and pulmonary circulation and on pneumoscintigraphic recording]. Cardaci G; Vittore F; Pigorini F Clin Ter; 1972 Oct; 63(2):131-51. PubMed ID: 4644527 [No Abstract] [Full Text] [Related]
22. The mechanism of potentiation of inotropic responses to phenylephrine by theophylline. Massingham R Br J Pharmacol; 1969 Oct; 37(2):540P-541P. PubMed ID: 4310586 [No Abstract] [Full Text] [Related]
23. [Effect of alpha, beta and other blockaders on color change in frogs]. Hagmüller K; Umrath K Z Biol; 1970 Jun; 116(5):394-7. PubMed ID: 4397258 [No Abstract] [Full Text] [Related]
24. Alpha-adrenoceptor antagonistic and calcium antagonistic effects of nicergoline in the rat isolated aorta. Heitz C; Descombes JJ; Miller RC; Stoclet JC Eur J Pharmacol; 1986 Apr; 123(2):279-85. PubMed ID: 3011463 [TBL] [Abstract][Full Text] [Related]
25. [Influence of xanthinol nicotinate on hyperlactacidemia induced by epinephrine and norepinephrine]. Brenner G Arzneimittelforschung; 1970 Dec; 20(12):1860-2. PubMed ID: 5537081 [No Abstract] [Full Text] [Related]
26. [Effect of catecholamines on the resistance and capacity of the coronary vessels]. Ovsiannikov VI Vestn Akad Med Nauk SSSR; 1973; 28(12):10-4. PubMed ID: 4150721 [No Abstract] [Full Text] [Related]
28. [Effects of a new vasoactive substance on renal hemodynamics]. Bologna E; Bossini A Minerva Med; 1973 Jul; 64(5):2663-8. PubMed ID: 4364432 [No Abstract] [Full Text] [Related]
29. [A review of pharmacological studies on nicergoline]. Moretti A; Arcari G; Pegrassi L Arzneimittelforschung; 1979; 29(8a):1223-7. PubMed ID: 44197 [TBL] [Abstract][Full Text] [Related]
30. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat. Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of platelet aggregation by anti-5-hydroxytryptaminic and alpha-adrenergic blocking agents. Fregnan GB Acta Univ Carol Med Monogr; 1972; 53():263-8. PubMed ID: 4151573 [No Abstract] [Full Text] [Related]
32. [Wallerox increases cerebral circulation and heart capacity]. Heynen U Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212 [No Abstract] [Full Text] [Related]
33. Centrally mediated cardiovascular effects of nicergoline in the dog compared to those of clonidine. Lièvre M; Morin MH; Lakhal M; Faucon G Eur J Pharmacol; 1985 Oct; 117(1):103-7. PubMed ID: 4085539 [TBL] [Abstract][Full Text] [Related]
34. Potentiation of the inhibitory effect of some antiaggregating drugs in " vitro". Polli EE; Praga C; Cortellaro M; Pogliani E Acta Univ Carol Med Monogr; 1972; 53():199-210. PubMed ID: 4670728 [No Abstract] [Full Text] [Related]
35. [A new series of compounds with alpha-sympatholytic, peripherally vasodilating and sedative effects]. Lindner E Arzneimittelforschung; 1972 Sep; 22(9):1445-8. PubMed ID: 4405010 [No Abstract] [Full Text] [Related]
36. Role of the alpha-receptor in the control of noradrenaline release from sympathetic nerves. Hedqvist P Acta Physiol Scand; 1974 Jan; 90(1):158-65. PubMed ID: 4149945 [No Abstract] [Full Text] [Related]
37. [Experimental arterial thrombosis. Effect of an alpha blocking agent: nicergoline]. Der Agopian P; Rosa A; Gautier JC; Lhermitte F Nouv Presse Med; 1973 Oct; 2(38):2521-4. PubMed ID: 4148699 [No Abstract] [Full Text] [Related]